Connection

ALAN SWANN to Drug Interactions

This is a "connection" page, showing publications ALAN SWANN has written about Drug Interactions.
Connection Strength

0.211
  1. Interactions between bipolar disorder and antisocial personality disorder in trait impulsivity and severity of illness. Acta Psychiatr Scand. 2010 Jun; 121(6):453-61.
    View in: PubMed
    Score: 0.073
  2. The role of MK-801 in sensitization to stimulants. Brain Res Brain Res Rev. 2001 Apr; 35(2):97-114.
    View in: PubMed
    Score: 0.040
  3. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Res Bull. 2000 Apr; 51(6):485-92.
    View in: PubMed
    Score: 0.037
  4. Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate. Brain Res. 2010 Feb 02; 1312:89-100.
    View in: PubMed
    Score: 0.018
  5. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003 Jul; 28(7):1374-82.
    View in: PubMed
    Score: 0.012
  6. Valproate prevents the induction and the expression of MK-801 sensitization. Brain Res. 2002 Nov 08; 954(2):151-9.
    View in: PubMed
    Score: 0.011
  7. Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats. Brain Res. 2000 Dec 29; 887(2):276-84.
    View in: PubMed
    Score: 0.010
  8. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Physiol Behav. 2000 Oct 1-15; 71(1-2):133-45.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.